ID   BW5147.G.1.4.OUAR.1
AC   CVCL_4137
AS   CVCL_4136
SY   BW5147.G.1.4.OUA-R.1; BW5147.G.1.4.OUA/R.1
DR   CLO; CLO_0002062
DR   CLO; CLO_0002063
DR   CLDB; cl513
DR   CLDB; cl514
DR   ATCC; CRL-1588
DR   BCRC; 60173
DR   ECACC; 85082302
DR   ECACC; 88100507
DR   JCRB; JCRB9002
DR   Wikidata; Q54798732
RX   PubMed=2365383;
CC   Group: Hybridoma fusion partner cell line.
CC   Doubling time: ~23 hours (Note=Lot 06212000) (JCRB=JCRB9002).
CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: AKR/J.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6315 ! BW5147.G.1.4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=2365383; DOI=10.1089/hyb.1990.9.285;
RA   Fernandez-Ruiz E., Silva A., Jotterand-Bellomo M.;
RT   "Karyotypic analysis of the AKR/J mouse thymoma cell line
RT   BW5147.G.1.4.OUAR.1.";
RL   Hybridoma 9:285-288(1990).
//